Founded in 2012 by brothers Jonathan and Richard Hodgson, Rokshaw Laboratories has grown from a wholesaler to a manufacturer of Specials and built a strong position in the Specials market in a very short space of time. This is a result of providing a personal service while delivering value to the NHS, as well as offering an ethical earning opportunity to community pharmacies across the UK.
Unlicensed medication supplied by Rokshaw Laboratories plays a vital role in improving patient treatment, increasing compliance and improving outcomes. Specials are often simply a different presentation of a commonly used drug. People can be allergic to an ingredient of a licensed line or need a drug that is either not yet licensed or is only licensed in another market.
One of the largest providers of ‘specials’ to independent pharmacies in the North East - the UK region with the highest demand for prescriptions of specials - Rokshaw can manufacture over 5,000 different formulations of drugs in a variety of dosage forms (such as creams, ointments, solutions and capsules) in its purpose-built, state-of-the-art laboratory.
The NEDCF investment will help to increase manufacturing efficiencies and support the development of innovative new products.
